top of page

Pharmacare Special Authority Update – Romosozumab coverage

Representatives of BCCOP, Osteoporosis Canada and MedAccess BC, have continued to advocate with the BC Ministry of Health to review PharmaCare criteria to enhance coverage of osteoporosis treatment.

BC PharmaCare has approved Romosozumab for coverage for postmenopausal women with osteoporosis with high risk of fractures via Special Authority Coverage with a Drug Coverage Decision.


Related Posts

See All


bottom of page